Biohelix Corporation

32 TOZER RD
Beverly, MA 01915

SBIR Award Summary

Total Number of Awards 28
Total Value of Awards $10.1MM
First Award Date 03/14/05
Most Recent Award Date 02/01/13

Key Personnel

Last Name Name Awards Contact
Kong Huimin Kong 20 Message
Lemieux Bertrand Lemieux 8 Message
Li Ying Li 1

28 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 02/01/13 - 01/31/14

DESCRIPTION (provided by applicant): In this Phase I project, we propose to investigate a novel primer chemistry and probe detection system called the Zip nucleic acids (ZNA"). ZNAs are oligonucleotides conjugated to a number of cationic spermine moieties that enhance the effective concentration of primers and probes near nucleic acid targets. ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): This STTR-AT-NIAID seeks to develop an integrated nucleic acid system based on research done by Catherine Klapperich's laboratory at Boston University. The BU lab-on-a-chip includes a micro solid phase extraction (<SPE) column, flap valves and hydrophobic vents to gate fluid movements through micro channels, ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 02/15/12 - 01/31/13

DESCRIPTION (provided by applicant): In this Phase I project, we propose to investigate a novel primer chemistry and probe detection system called the Zip nucleic acids (ZNA"). ZNAs are oligonucleotides conjugated to a number of cationic spermine moieties that enhance the effective concentration of primers and probes near nucleic acid targets. ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 09/30/11 - 08/31/12

DESCRIPTION (provided by applicant): This STTR-AT-NIAID seeks to develop an integrated nucleic acid system based on research done by Catherine Klapperich's laboratory at Boston University. The BU lab-on-a-chip includes a micro solid phase extraction (<SPE) column, flap valves and hydrophobic vents to gate fluid movements through micro channels, ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/01/11 - 06/30/12

DESCRIPTION (provided by applicant): This SBIR-AT-NIAID Phase I application addresses the problem of malaria diagnostics in resource- limited settings. BioHelix, has developed an isothermal nucleic acid amplification chemistry called helicase dependent amplification (HDA) that is tolerant of the DNA amplification inhibitors present in whole bloo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 04/01/11 - 03/31/13

DESCRIPTION (provided by applicant): We propose to develop a rapid, low cost, threshold assay for the detection of HIV infection of HIV vaccination trial participants. The assay we propose to develop will use our proprietary helicase dependent amplification (HDA) platform as well as a low cost device specifically designed to perform molecular te...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 07/15/10 - 06/30/11

DESCRIPTION (provided by applicant): This SBIR-AT-NIAID Phase I application addresses the problem of malaria diagnostics in resource- limited settings. BioHelix, has developed an isothermal nucleic acid amplification chemistry called helicase dependent amplification (HDA) that is tolerant of the DNA amplification inhibitors present in whole bloo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 04/01/10 - 03/31/12

DESCRIPTION (provided by applicant): The objective of our NIAID Biodefense Phase I SBIR program was to develop, and commercialize field deployable nucleic acid analysis devices for use in biodefense applications. We have begun to sell IsoAmp II kits that will allow our clients to develop home brew assays (we list customers in the commercializat...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 04/01/10 - 03/31/12

DESCRIPTION (provided by applicant): The objective of our NIAID Biodefense Phase I SBIR program was to develop, and commercialize field deployable nucleic acid analysis devices for use in biodefense applications. We have begun to sell IsoAmp II kits that will allow our clients to develop home brew assays (we list customers in the commercializat...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 04/01/10 - 03/31/11

DESCRIPTION (provided by applicant): We propose to develop a rapid, low cost, threshold assay for the detection of HIV infection of HIV vaccination trial participants. The assay we propose to develop will use our proprietary helicase dependent amplification (HDA) platform as well as a low cost device specifically designed to perform molecular te...

Load More